The effectiveness of PD-1 inhibitors in non-small cell lung cancer (NSCLC) patients of different ages

BACKGROUND: Immunosenescence, the age-related decline of immunity, affects the immune responses of non-small cell lung cancer (NSCLC) patients. Through immune responses, programmed death-1 (PD-1) inhibitors exert their antitumor robustness. In different ages of NSCLC patients, especially the older p...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yingcheng, Ju, Qianqian, Qian, Bei, Zhang, Feng, Shi, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814271/
https://www.ncbi.nlm.nih.gov/pubmed/29487704
http://dx.doi.org/10.18632/oncotarget.23678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814271/
https://www.ncbi.nlm.nih.gov/pubmed/29487704
http://dx.doi.org/10.18632/oncotarget.23678

Ejemplares similares